MedTrace Logo

Effect of Coccinia Cordifolia Extract on Blood Sugar of Newly Diagnosed Diabetics

NCT00502008 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2007-07-17

No results posted yet for this study

Summary

The purpose of the study was to evaluate the effectiveness of Coccinia Cordifolia (synonym Coccinia indica) on the blood glucose levels of newly detected type 2 diabetic patients requiring only behavioral or lifestyle intervention. The hypothesis of the study is that there will be significant decrease in the blood glucose levels after a period of 90 days in the diabetic patients who consumed the coccinia extract.

Conditions

Interventions

DRUG

Coccinia Cordifolia (herbal extract)

Sponsors & Collaborators

  • Gencor Pacific Group

    collaborator INDUSTRY

  • St. John's Research Institute

    lead OTHER

Principal Investigators

  • Anura V Kurpad, MD, PhD · St. John's Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-11-30
Completion
2007-05-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00502008 on ClinicalTrials.gov